Work

Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-mediated Autoimmune Diseases (P4-14.016)

Year: 2024

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000206331

Authors: Tuan Vu, Kelly Gwathmey, Catherine Broome, Matthias Goebeler, Hiroyuki Murai, Zsuzsanna Bata-Csörgo, Adrian Newland, Peter Ulrichts, Rene Kerstens, Jeffrey T. Guptill, Sofiane Agha, Ming Jiang, James Howard

Institutions: University of South Florida, Virginia Commonwealth University, Georgetown University, Universitätsklinikum Würzburg, International University of Health and Welfare, University of Szeged, Queen Mary University of London, Argenx (Belgium), University of North Carolina at Chapel Hill

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4394600003

FWCI:

Cites:

Cited by:

Related to: 10